After Protracted Sell-Off, Amphastar Looks Like A Value Pick [Seeking Alpha]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Seeking Alpha
AMPH beat revenue and EPS estimates in Q2, with BAQSIMI sales up 21% YoY, offsetting declines in legacy generics. The company is vastly expanding US manufacturing and advancing new drugs, including AMP-002 (recently FDA approved) and AMP-004 (insulin aspart generic). Despite sector risks and US policy uncertainty, AMPH's profitability and discounted valuation make it an appealing value play for 2025. Evgeniya Pavlova/iStock via Getty Images Last year, I wrote about pharmaceutical company Amphastar Pharmaceuticals, Inc. ( NASDAQ: AMPH ). I labeled it a buy based on expected growth with the acquisition of BAQSIMI, but with market pessimism surrounding the healthcare industry, the stock's performance just wasn't there, and instead This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call opti
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals: Why I Like Bull Put Options Strategy Here [Seeking Alpha]Seeking Alpha
- Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH) [Yahoo! Finance]Yahoo! Finance
- Wells Fargo Sees Amphastar Pharmaceuticals, Inc.'s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth [Yahoo! Finance]Yahoo! Finance
- Amphastar FDA Wins And Pipeline Expansion Contrast With Weak Earnings And Valuation [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 2/26/26 - Miss
AMPH
Sec Filings
- 3/16/26 - Form 8-K
- 3/11/26 - Form 4
- 3/11/26 - Form 4
- AMPH's page on the SEC website